Notably, LAG-3 and PD-1 are co-expressed at high levels in tumor infiltrating lymphocytes in certain tumor model mice and the inhibition of both molecules enhances CD8+ effector T cell numbers [73,74,75]. The gene discussed is CD8A; the disease is neoplasm.